Real-World Treatment Patterns according to Clinical Practice Guidelines in Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Korea: Multicenter, Retrospective, Observational Study

양예슬 ,  김남훈 ,  백종하 외 13명

Diabetes and Metabolism Journal

2024 .03

SGLT2 Inhibitors and GLP-1 Agonists: A Beacon of Hope for Stroke Prevention in Diabetes

전재한

Diabetes and Metabolism Journal

2024 .03

Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists

강유미 ,  정창희

Endocrinology and Metabolism

2016 .01

Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists

Tzu-Yi Lin ,  Eugene Yu-Chuan Kang ,  Shih-Chieh Shao 외 10명

Diabetes and Metabolism Journal

2023 .05

Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association

김현진 ,  박석오 ,  고승현 외 7명

Diabetes and Metabolism Journal

2017 .01

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes

이승아 ,  이동윤

Annals of Pediatirc Endocrinology & Metabolism

2017 .01

당뇨병을 동반하지 않는 심부전 환자에서 SGLT2 Inhibitor의 심장기능에 대한 효과

이하늘 ,  이해원 ,  금민정 외 4명

병원약사회지

2024 .08

GLP-1 Based Combination Therapy for Obesity and Diabetes

이영희 ,  Hee Won Lee ,  최형진

Journal of Obesity & Metabolic Syndrome

2017 .01

Are sodium-glucose co-transporter-2 inhibitors associated with improved outcomes in diabetic patients admitted to intensive care units with septic shock?

Ashche ,  kin Nikita ,  Abdalla Abdelmohaymin A. 외 8명

Acute and Critical Care

2024 .05

A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans

Jack Alistai ,  Sa ,  geant 외 5명

Endocrinology and Metabolism

2019 .01

The Efficacy of Treatment Intensification by Quadruple Oral Therapy Compared to GLP-1RA Therapy in Poorly Controlled Type 2 Diabetes Mellitus Patients: A Real-world Data Study

김민영 ,  김호수 ,  Kim Kyong Young 외 5명

Diabetes and Metabolism Journal

2023 .01

SGLT2 Inhibitor, an Agent for Diabetes, Heart, Kidney… and Stroke

Taeil Yang ,  Jooyeon Lee ,  Jaewon Oh

Korean Circulation Journal

2024 .09

새로운 심부전 약제, SGLT2 억제제

조동혁

대한내과학회지

2023 .04

SGLT2 Inhibitors: the Gift that Keeps on Giving

Ma ,  ia Victo ,  ia Faith Ga 외 2명

Korean Circulation Journal

2021 .01

Metformin에 추가로 병용되는 SGLT2 inhibitors의 효능과 안전성에 관한 고찰

정경혜

한국임상약학회지

2018 .01

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Understanding How Data Can Inform Clinical Practice in Korea

전숙 ,  안규정 ,  정인경 외 2명

Diabetes and Metabolism Journal

2015 .01

Superior heart failure protecting effect of selective SGLT2 inhibitor than non-selective SGLT1,2 inhibitor in the diabetic heart failure zebrafish model

Inho Kim

한국실험동물학회 학술발표대회 논문집

2022 .01

GLP regulation for medical device

Maeng Eun Ho

한국실험동물학회 학술발표대회 논문집

2017 .08

Insulin/GLP-1 Treatment for Patients with DM

Zacho ,  Mette

Journal of mucopolysaccharidosis and rare disease

2016 .01

Cardioprotective Potential of an SGLT2 Inhibitor Against Doxorubicin-Induced Heart Failure

Chang-Myung Oh

Korean Circulation Journal

2019 .01